Efficacy of carboplatin-based preoperative chemotherapy for triple-negative breast cancer
Authors:
Open Access
- 1 January 2017
- journal article
- research article
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 38 (1) , 18-23
Abstract
Efficacy of carboplatin-based preoperative chemotherapy for triple-negative breast cancer. A meta-analysis of randomized controlled trialsKeywords
This publication has 26 references indexed in Scilit:
- Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trialThe Lancet Oncology, 2014
- Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpressionBreast Cancer Research and Treatment, 2014
- Neoadjuvant bevacizumab and anthracycline–taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)Annals of Oncology, 2013
- A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter studyBreast Cancer Research and Treatment, 2012
- Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer NetworkCancer, 2012
- Characteristics of Triple-Negative Breast Cancer in Patients With a BRCA1 Mutation: Results From a Population-Based Study of Young WomenJournal of Clinical Oncology, 2011
- Preoperative chemotherapy for women with operable breast cancerCochrane Database of Systematic Reviews, 2007
- Triple-negative breast cancer: therapeutic optionsThe Lancet Oncology, 2007
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.Journal of Clinical Oncology, 1998